ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,514.00
      1.00%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,831.43
      -0.12%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. LAVA Therapeutics NV (LVTX)

      7. LAVA Therapeutics NV (LVTX) Financials

      LAVA Therapeutics NV

      LAVA Therapeutics NV (LVTX)

      NASDAQ
      2.07
      -0.04
      (-1.90%)
      Closed July 27 4:00PM
      Delayed by 15 minutes
      2.11
      0.04
      (1.93%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      LAVA Therapeutics NV Financial Summary

      The current LVTX market cap is 54.42M. The company's latest EPS is USD -1.5966 and P/E is -1.32.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 1.22M5.14M53k353k6.99M
      Operating Income -13.54M-13.55M-18.31M-15.89M-1.95M
      Net Income -13.94M-12.7M-8.84M-6.5M-553k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 03.5M5.35M19.39M6.77M
      Operating Income -9.58M-14.92M-43.61M-34.84M-43.25M
      Net Income -9.69M-15.51M-42.36M-31.91M-41.97M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 135.28M122.54M111.02M101.71M99.08M
      Total Liabilities 60.01M58.65M56.42M50.53M48.41M
      Total Equity 75.28M63.89M54.6M51.18M50.67M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 8.8M20.49M139.25M143.43M101.71M
      Total Liabilities 2.95M12.87M20.88M57.39M50.53M
      Total Equity 5.84M7.62M118.37M86.04M51.18M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -8.34M-21.4M-28.85M-38.97M-1.13M
      Investing 7.68M7.9M-8.95M-17.64M718k
      Financing -97k-254k-391k-571k N/A
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -8.62M-9.31M-28.65M4.04M-38.97M
      Investing -792k-502k-43.55M9.35M-17.64M
      Financing 1.18M18.97M151.16M283k-571k

      Stats and Ratios

      Market Cap 54.42M
      Price to Earnings Ratio -1.32
      Price to Sales Ratio 8.19
      Price to Cash Ratio 1.25
      Price to Book Ratio 1.08
      Dividend Yield -

      Share Statistics

      Shares Outstanding 26.29M
      Average Volume (1 week) 87.9k
      Average Volume (1 Month) 95.1k
      52 Week Change 8.38%
      52 Week High 6.47
      52 Week Low 1.131
      Spread (Intraday) 0.14 (6.39%)

      Company Info

      Company Name LAVA Therapeutics NV
      Address yalelaan 62
      utrecht, utrecht 3584 CM
      Website https://www.lavatherapeutics.com
      Industry pharmaceutical preparations (2834)